BioNTech (BNTX) PT Lowered to $195 at Morgan Stanley
Tweet
Share
E-mailGet Alerts BNTX Hot Sheet
Price: $96.90 +0.05%
Rating Summary:
16 Buy, 7 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 14 | Down: 15 | New: 50
Rating Summary:
16 Buy, 7 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 14 | Down: 15 | New: 50
Join SI Premium – FREE
Morgan Stanley analyst Matthew Harrison lowered the price target on BioNTech (NASDAQ: BNTX) to $195.00 (from $197.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Macquarie Upgrades Merdeka Gold Resources (EMAS:IJ) to Neutral
- JPMorgan Upgrades Sandfire Resources NL (SFR:AU) (SNDFY) to Overweight
- TMBThanachart Bank PCL (TTB:TB) PT Raised to THB3.30 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
